Page 3 - புனே சீரம் நிறுவனம் ஆஃப் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India Considers Studies On Fertile Area Of Mix And Match Of Covid-19 Vaccines: Official

India Considers Studies On Fertile Area Of Mix And Match Of Covid-19 Vaccines: Official
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

United kingdomWorld health organizationPune serum institute of indiaSerum instituteBharat biotechZydus cadilaHyderabad based bioeஒன்றுபட்டது கிஂக்டம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்புனே சீரம் நிறுவனம் ஆஃப் இந்தியாசீரம் நிறுவனம்பாரத் பயோடெக்ஜய்துச் காடிலா

Jaishankar talks of dishonoured commitments during COVID-19 pandemic

Pandemic has prompted countries to become self-seeking often resorting to broader definition of national security that disrupted supply chains, he notes

United statesSri lankaAdar poonawallahPune serum institute of indiaExternal affairs ministerVaccine maitriSouth asianBangladesh foreign ministerSerum instituteS jaishankarVaccine maitri projectUture of asia eventஒன்றுபட்டது மாநிலங்களில்ஸ்ரீ லங்காபுனே சீரம் நிறுவனம் ஆஃப் இந்தியாவெளிப்புறம் வாழ்க்கைத்தொழில்கள் அமைச்சர்

Govt Panel Wants 12-16 Week Gap Between Covishield Doses, No Change For Covaxin

Govt Panel Wants 12-16 Week Gap Between Covishield Doses, No Change For Covaxin News18 1 hour ago Runjhun Sharma © Provided by News18 Govt Panel Wants 12-16 Week Gap Between Covishield Doses, No Change For Covaxin An expert panel of the government recommended on Thursday that the gap between two doses of the Covishield vaccine be increased to 12-16 weeks. However, no change has been suggested for Bharat Biotech’s Covaxin, whose gap between the two doses stands at four to six weeks. The development comes in the wake of India facing an acute shortage of vaccine supply amid the catastrophic second wave.

South africaUnited kingdomPune serum institute of indiaGovt panelGovt panel wantsGap between covishield dosesPanel wantsBharat biotechSerum instituteஒன்றுபட்டது கிஂக்டம்புனே சீரம் நிறுவனம் ஆஃப் இந்தியாஅரசு குழுகுழு விரும்புகிறதுபாரத் பயோடெக்சீரம் நிறுவனம்

Covid-19 Vaccination: In A First, More Second Doses Administered Than First Jabs In May

Covid-19 Vaccination: In A First, More Second Doses Administered Than First Jabs In May Aman Sharma © Provided by News18 Covid-19 Vaccination: In A First, More Second Doses Administered Than First Jabs In May For the first time since vaccinations in India began in January, more second doses have been administered to beneficiaries than first doses so far in May, showing that both the Centre and state governments are now focusing on first completing the inoculation drive for people in priority groups. Government data analysed by News18 showed that out of 16.8 million jabs given across the country till now in May, nearly 8.9 million were second doses, while first doses stood at 7.9 million. Of the first doses, 2.5 million jabs were given to the 18-44 age group; vaccination began for this section on May 1. The numbers meant just 5.4 million people in the 45+ age group, or health or frontline workers got their first doses this month. Before this, weekly or monthly

United kingdomTamil naduUttar pradeshOxford astrazeneca covishieldPune serum institute of indiaAndhra pradeshWest bengalSerum instituteஒன்றுபட்டது கிஂக்டம்தமிழ் நாடுஉத்தர் பிரதேஷ்புனே சீரம் நிறுவனம் ஆஃப் இந்தியாஆந்திரா பிரதேஷ்மேற்கு பெங்கல்சீரம் நிறுவனம்

Bangladesh opts for China s vaccine

Bangladesh opts for China’s vaccine Updated: Updated: Decision comes as India has delayed delivery of Covishield vaccine in recent weeks Share Article Decision comes as India has delayed delivery of Covishield vaccine in recent weeks Bangladesh will receive a major consignment of China-made vaccine doses for the pandemic which will arrive on Wednesday. This will be the first time that Bangladesh will receive the Chinese vaccine in such a large quantity since the beginning of the pandemic last year as India has delayed delivery of Covishield vaccine in recent weeks. “China is dedicated to international vaccine cooperation. It’s the latest outcome of China-Bangladesh anti-pandemic cooperation,” said China’s Ambassador to Bangladesh Li Jiming in a press conference announcing that the Sinopharm vaccine will arrive in Dhaka this week. Sinopharm is among the few globally recognised vaccines that are cleared for emergency use by the World Health Organisation.

Li jimingSheikh hasinaPune serum institute of indiaWorld health organisationBangladesh li jimingWorld healthSerum institutePrime minister sheikh hasinaPrime minister narendra modiஷேக் ஹசினாபுனே சீரம் நிறுவனம் ஆஃப் இந்தியாஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்உலகம் ஆரோக்கியம்சீரம் நிறுவனம்ப்ரைம் அமைச்சர் ஷேக் ஹசினாப்ரைம் அமைச்சர் நரேந்திர மோடி